NDC 69336-330

Revesta

Revesta

Revesta is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sterling Knight Pharmaceuticals,llc. The primary component is Cholecalciferol; Folic Acid.

• Product ID: 69336-330_0206c671-3014-44b9-b3e8-4357f393452b
• NDC: 69336-330
• Product Type: Human Prescription Drug
• Proprietary Name: Revesta
• Generic Name: Revesta
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2016-10-13
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sterling Knight Pharmaceuticals,LLC
• Substance Name: CHOLECALCIFEROL; FOLIC ACID
• Active Ingredient Strength: 5750 [iU]/1; mg/1
• Pharm Classes: Vitamin D [CS],Vitamin D [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 69336-330-30

30 CAPSULE in 1 BOTTLE, PLASTIC (69336-330-30)

• Marketing Start Date: 2016-10-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 69336-330-30 [69336033030]

Revesta CAPSULE

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-10-13

Drug Details

Active Ingredients

Ingredient	Strength
CHOLECALCIFEROL	5750 [iU]/1

OpenFDA Data

• SPL SET ID: e5567a73-bf94-4bad-ade6-ddef18c8af04
• Manufacturer:
  • Sterling Knight Pharmaceuticals,LLC
• UNII:
  • 1C6V77QF41
  • 935E97BOY8
• RxNorm Concept Unique ID - RxCUI:
  • 1601102
• UPC Code:
  • 0369336330305

Pharmacological Class

• Vitamin D [CS]
• Vitamin D [EPC]